Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2021 1
2024 1
2025 2
2026 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5 results

Results by year

Filters applied: . Clear all
Page 1
Caution Is Warranted in Prescribing Ketamine for Mental Health.
Drabiak K. Drabiak K. J Gen Intern Med. 2026 Apr;41(5):1394-1398. doi: 10.1007/s11606-025-10024-8. Epub 2025 Nov 12. J Gen Intern Med. 2026. PMID: 41225232
Ketamine has expanded into a multibillion-dollar industry, with three delivery models: (1) in-person clinics offering off-label racemic ketamine; (2) clinic visits for esketamine (Spravato); and (3) telehealth services prescribing off-label racemic ketamine. ...
Ketamine has expanded into a multibillion-dollar industry, with three delivery models: (1) in-person clinics offering off-label racemic keta …
Statewide Ketamine and Esketamine Prescribing Trends in Rhode Island, 2017-2023.
Paiva TJ, Hallowell BD, Fischer S, Bratberg J, St John K, Nitenson AZ, Wightman RS. Paiva TJ, et al. R I Med J (2013). 2024 Oct 1;107(10):26-32. R I Med J (2013). 2024. PMID: 39331010 Free article.
This report compares statewide prescription ketamine and esketamine trends. Using PDMP data from 2017-2023, prescription and prescriber characteristics, and patient demographics were compared between esketamine and ketamine prescriptions. ...As more people seek trea …
This report compares statewide prescription ketamine and esketamine trends. Using PDMP data from 2017-2023, prescription and prescrib …
Ketamine as a Mental Health Treatment.
Braun L, Colbert A. Braun L, et al. Am J Nurs. 2026 Mar 1;126(3):24-30. doi: 10.1097/AJN.0000000000000250. Epub 2026 Feb 19. Am J Nurs. 2026. PMID: 41709389
Additionally, the S-ketamine enantiomer of ketamine, esketamine (marketed as Spravato), received approval for treatment-resistant depression in 2019. Clinical applications of ketamine in the treatment of mental health disorders include intranasal administration (esketam …
Additionally, the S-ketamine enantiomer of ketamine, esketamine (marketed as Spravato), received approval for treatment-resistant dep …
Mapping the Use of Ketamine in Treatment-Resistant Depression and Other Psychiatric Disorders: A Scoping Review of Practice Patterns, Efficacy, and Patient Demographic Trends.
Aslam AM, Shinozuka K, Muir O, Tabaac BJ. Aslam AM, et al. Am J Ther. 2025 May-Jun 01;32(3):e242-e246. doi: 10.1097/MJT.0000000000001951. Epub 2025 Apr 15. Am J Ther. 2025. PMID: 40338681 Free PMC article.
Although intravenous (IV) ketamine is not approved by the Food and Drug Administration (FDA) for TRD, esketamine, an FDA-approved therapeutic, has contributed to the widespread clinical use of off-label IV ketamine across the United States. This scoping review highlights s …
Although intravenous (IV) ketamine is not approved by the Food and Drug Administration (FDA) for TRD, esketamine, an FDA-approved the …